Inversely BAP1 expression was found to increase the effect of gemcitabine in mesothelioma cell lines, showing that the expression of BAP1 may affect outcomes differently according to type of chemotherapy (Guazzelli et al. 2019). Here, BAP1 is linked to mesothelioma.